“Wistar researchers have found rationale for repurposing a class of antitumor compounds called HDAC inhibitors, already approved by the FDA for the… View more
The Tina’s Wish Junior Advisory Board hosted their third annual Trivia Night on March 15th at the Cutting Room. 188 guests enjoyed… View more
Joan Janssen, an ovarian cancer patient at Dana-Farber, speaks about the development of targeted therapies and how she is using them to… View more
Investigators from Brigham and Women’s Hospital and Dana-Farber Cancer Institute, including Tina’s Wish researchers, Dipanjan Chowdhury, PhD, and Kevin Elias, MD, are… View more
Thursday, October 26, 2017 The Tina’s Wish inaugural Richmond Gathering at The Country Club of Virginia was attended by 110 supporters who… View more
A preliminary study of ovarian cancer finds that in most cases it actually arises in the Fallopian tubes. If confirmed, the study could… View more
